Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
131i-lipiodol (Lipiodol) (1 trial)
epirubicin (ellence) (1 trial)
gelatin (1 trial)
Carcinoma, Hepatocellular (Phase 3)
Thrombosis (Phase 3)
Trials (1 total)
Trial APIs (3 total)